Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000376611

Medchemexpress LLC CE-224535 (PF-04905428) | 724424-43-5 | C22H29ClN4O6 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY1548750MG

Encompass_Preferred

CE-224535 is a selective P2X7 receptor antagonist developed as a disease-modifying antirheumatic drug (DMARD). It acts as a selective antagonist of the human P2X7 receptor, reducing the secretion of IL-1 and IL-18 from leukocytes, suggesting a potential new therapeutic approach for the treatment of rheumatoid arthritis (RA).

  • Selective P2X7 receptor antagonist
  • Developed as a disease-modifying antirheumatic drug (DMARD)
  • Reduces leukocyte secretion of IL-1 and IL-18
  • Potential therapeutic approach for rheumatoid arthritis
  • For research use only

Catalog No. 50-003-76611


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.